USC Michelson CSI-Cancer
@uscmichelsoncsi
ID: 1038185789232795649
http://kuhn.usc.edu 07-09-2018 22:02:35
377 Tweet
278 Takipçi
143 Takip Edilen
Michelson Center for Convergent Bioscience’s Drs. Stephanie Shishido and Peter Kuhn, collaborated with a team of researchers on a Phase I study examining a CAR T cell therapy in metastatic castration-resistant prostate cancer. Findings from the study were published in
Addressing the Logistics of At-Home Cancer Care With Subcutaneous Administration of Immunotherapy Jorge Nieva USC Norris COE Keck Medicine of USC #oncology #lcsm #MedTwitter onclive.com/view/addressin…
Fellow Whovians! How would the Time Lords' dual cardiac system actually work? Dornsife alumna and Doctor Who superfan Amelia Marvit has you covered in Scientific American. scientificamerican.com/article/doctor…
Interested in the future of #precisionmedicine and how collaborative efforts can drive significant advancements in #cancer Dx and Tx? Listen to BLOODPAC and JCO Precision Oncology podcast discussion on the transformative impact of #liquidbiopsies in #cancercare: ascopubs.org/do/recommendat…
📺 WATCH: Saul Priceman, PhD, discuss the benefit of using CAR T-cell therapy for patients with metastatic castration-resistant prostate cancer. #pcsm | Saul “Cancer Asskicker” Priceman cancernetwork.com/view/assessing…
"These crazy thought experiments are where I get to apply all the things I've been learning." How a young Doctor Who on BBC America superfan's cross-disciplinary thinking led to an article in Scientific American.
"Knowing that there’s so much potential to detect cancer sooner is very exciting". With cancer affecting one in three Americans, USC Dornsife College of Letters, Arts & Sciences's Anya Shah is focused on a future where early detection changes everything.
What if you could detect cancer with just a blood test? USC Dornsife College of Letters, Arts & Sciences's Peter Kuhn is turning that possibility into reality, developing liquid biopsy technology that spots cancer early, long before it spreads — and long before it becomes life-threatening. dornsife.usc.edu/magazine/cance…
Big day for BLOODPAC's collaborative studies with The Breast Cancer Research Foundation and the Prostate Cancer Foundation! Both organizations shared updates on studies that began in 2016. Thank you to both organizations for their early commitment and support of BLOODPAC's mission!